Published in Emerg Infect Dis on February 01, 2010
Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One (2012) 1.52
Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis (2012) 1.45
Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis (2014) 1.43
Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol (2014) 1.07
Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis (2012) 0.94
Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. PLoS One (2013) 0.94
SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One (2011) 0.93
Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Hum Immunol (2014) 0.88
Bordetella pertussis evolution in the (functional) genomics era. Pathog Dis (2015) 0.87
Direct molecular typing of Bordetella pertussis from nasopharyngeal specimens in China in 2012-2013. Eur J Clin Microbiol Infect Dis (2016) 0.75
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol (2004) 2.58
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis (2001) 2.41
Resurgence of pertussis in Europe. Pediatr Infect Dis J (2005) 2.23
Epidemiology of pertussis. Pediatr Infect Dis J (2005) 1.84
What is new in pertussis? Eur J Pediatr (2007) 1.52
Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol (2009) 1.48
Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol (2005) 1.41
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10
Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect (2004) 1.10
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis (2006) 0.88
Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis. J Microbiol Methods (2009) 0.86
Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol (2006) 14.53
Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet (2006) 6.43
First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis (2009) 3.18
A recalibrated molecular clock and independent origins for the cholera pandemic clones. PLoS One (2008) 3.16
Serotype identification of group B streptococci by PCR and sequencing. J Clin Microbiol (2002) 2.86
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog (2005) 2.71
Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci. J Bacteriol (2007) 2.67
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol (2004) 2.58
Genomic sequencing reveals regulatory mutations and recombinational events in the widely used MC4100 lineage of Escherichia coli K-12. J Bacteriol (2009) 2.51
Escherichia coli in disguise: molecular origins of Shigella. Microbes Infect (2002) 2.27
Structure and genetics of Shigella O antigens. FEMS Microbiol Rev (2008) 2.11
Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol (2002) 2.02
Genetic relatedness of the Streptococcus pneumoniae capsular biosynthetic loci. J Bacteriol (2007) 1.92
Derivation of Escherichia coli O157:H7 from its O55:H7 precursor. PLoS One (2010) 1.90
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Species-wide variation in the Escherichia coli flagellin (H-antigen) gene. J Bacteriol (2003) 1.73
Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis (2003) 1.73
Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri. J Clin Microbiol (2009) 1.71
Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J (2008) 1.69
A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine (2002) 1.68
A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR. J Med Microbiol (2005) 1.67
Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J Clin Microbiol (2007) 1.67
Multiplex PCR-based reverse line blot hybridization assay (mPCR/RLB)--a practical epidemiological and diagnostic tool. Nat Protoc (2006) 1.66
Evolution of seventh cholera pandemic and origin of 1991 epidemic, Latin America. Emerg Infect Dis (2010) 1.66
Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One (2010) 1.61
Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes. J Clin Microbiol (2006) 1.60
Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect Immun (2004) 1.59
Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization. J Med Microbiol (2005) 1.59
Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J Clin Microbiol (2009) 1.58
Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J Clin Microbiol (2002) 1.54
The O-antigen gene cluster of Escherichia coli O55:H7 and identification of a new UDP-GlcNAc C4 epimerase gene. J Bacteriol (2002) 1.50
Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology (2002) 1.46
Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer. Clin Infect Dis (2011) 1.45
Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol (2013) 1.44
Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis (2014) 1.43
Single-nucleotide-polymorphism typing and genetic relationships of Salmonella enterica serovar Typhi isolates. J Clin Microbiol (2007) 1.43
Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One (2011) 1.40
Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: a decision analysis. Tuberculosis (Edinb) (2006) 1.40
Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes. J Med Microbiol (2003) 1.40
Recent increases in mumps incidence in Australia: the "forgotten" age group in the 1998 Australian Measles Control Campaign. Med J Aust (2008) 1.38
Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect (2005) 1.36
Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases. J Am Med Inform Assoc (2003) 1.36
Genetic diversity and molecular typing of Listeria monocytogenes in China. BMC Microbiol (2012) 1.35
Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One (2012) 1.35
Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics (2010) 1.33
Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care. J Am Med Inform Assoc (2005) 1.33
Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis (2003) 1.29
Multiple-locus variable-number tandem-repeat analysis of Salmonella enterica serovar Typhi. J Clin Microbiol (2009) 1.29
Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics (2008) 1.26
Improving resolution of public health surveillance for human Salmonella enterica serovar Typhimurium infection: 3 years of prospective multiple-locus variable-number tandem-repeat analysis (MLVA). BMC Infect Dis (2012) 1.26
Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS One (2007) 1.26
Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp. J Clin Microbiol (2006) 1.24
Vibrio cholerae pathogenic clones. Emerg Infect Dis (2005) 1.24
Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine (2013) 1.24
Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc Biol Sci (2005) 1.24
Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol (2009) 1.24
Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust (2011) 1.22
Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis (2012) 1.22
Pandemic spread of cholera: genetic diversity and relationships within the seventh pandemic clone of Vibrio cholerae determined by amplified fragment length polymorphism. J Clin Microbiol (2002) 1.21
Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother (2006) 1.20
Use of PCR and reverse line blot hybridization assay for rapid simultaneous detection and serovar identification of Chlamydia trachomatis. J Clin Microbiol (2006) 1.20
Towards a genotyping system for Streptococcus agalactiae (group B streptococcus): use of mobile genetic elements in Australasian invasive isolates. J Med Microbiol (2003) 1.18
Population structure of Helicobacter pylori among ethnic groups in Malaysia: recent acquisition of the bacterium by the Malay population. BMC Microbiol (2009) 1.17
Divergence involving global regulatory gene mutations in an Escherichia coli population evolving under phosphate limitation. Genome Biol Evol (2010) 1.17
Pathogen profiling for disease management and surveillance. Nat Rev Microbiol (2007) 1.17
Identification of non-tuberculous mycobacteria: utility of the GenoType Mycobacterium CM/AS assay compared with HPLC and 16S rRNA gene sequencing. J Med Microbiol (2009) 1.16
Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol (2010) 1.15
Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health (2004) 1.15
Structural diversity in Salmonella O antigens and its genetic basis. FEMS Microbiol Rev (2013) 1.15
Identification of less-common Streptococcus pneumoniae serotypes by a multiplex PCR-based reverse line blot hybridization assay. J Clin Microbiol (2007) 1.15
secA1 gene sequence polymorphisms for species identification of Nocardia species and recognition of intraspecies genetic diversity. J Clin Microbiol (2010) 1.15
Use of PCR and reverse line blot hybridization macroarray based on 16S-23S rRNA gene internal transcribed spacer sequences for rapid identification of 34 mycobacterium species. J Clin Microbiol (2006) 1.15
Minimum core genome sequence typing of bacterial pathogens: a unified approach for clinical and public health microbiology. J Clin Microbiol (2013) 1.15
Identification and characterization of a novel Shigella flexneri serotype Yv in China. PLoS One (2013) 1.14
Population structure, origins and evolution of major Salmonella enterica clones. Infect Genet Evol (2009) 1.13
Improving pertussis vaccination. Hum Vaccin (2009) 1.12
A novel plasmid-encoded serotype conversion mechanism through addition of phosphoethanolamine to the O-antigen of Shigella flexneri. PLoS One (2012) 1.12
Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine (2007) 1.12
Reverse line blot assay for direct identification of seven Streptococcus agalactiae major surface protein antigen genes. Clin Vaccine Immunol (2006) 1.11
Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae). J Clin Microbiol (2006) 1.11
Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun (2008) 1.09
Development of multiplex PCR assays for the identification of the 33 serotypes of Streptococcus suis. PLoS One (2013) 1.08
Diagnosing tuberculous meningitis - have we made any progress? Trop Med Int Health (2013) 1.07